Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for ...

Neurizon Therapeutics (ASX: NUZ) has announced encouraging outcomes from an independent study assessing its neuroprotective ...

Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.

Neurizon teams up with Tessara for further testing on its ... Read More The post StockTake: Neurizon’s potential cure for ...

Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Neurizon Therapeutics Limited (NUZ). However, you won't necessarily see their names in the ...

Neurizon Therapeutics (ASX: NUZ) has reported positive results from an independent study into the effects of neuroprotective ...

Neurizon Therapeutics' (ASX:NUZ) lead drug candidate has demonstrated positive results in the latest round of testing with ...

In a big step forward in the development of NUZ-001, Neurizon teams up with Tessara for further testing on its lead candidate.

A copy of the poster presentation by Dr Greenough at AD/PD can be found in the original announcement on Neurizon Therapeutics Investor Hub. Tessara Therapeutics is a Melbourne-based biotechnology ...